}

Memphis Pharmaceutical’s profits soar 188% in 6 months

Updated 1/30/2023 2:59:00 PM
Memphis Pharmaceutical’s profits soar 188% in 6 months

Arab Finance: Memphis Pharmaceutical’s (MPCI) profits after tax amounted to EGP 27.56 million in the six-month period ended December 31st, 2022, up by 188% year-on-year (YoY) from EGP 9.59 million, according to the financial income statement filed to the Egyptian Exchange (EGX) on January 30th.

Sales saw an 18% hike in the July-December period of 2022 to EGP 302.65 million, compared to EGP 257.23 million in the year-ago period.

Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.

Related News

EGX closes Thursday on varied note Updated 11/19/2026 3:19:00 PM
EGX closes Wednesday in red zone Updated 11/18/2026 3:16:00 PM
EGX indices flag in red on Tuesday Updated 11/17/2026 3:59:00 PM